<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00673803</url>
  </required_header>
  <id_info>
    <org_study_id>preloaded 2008</org_study_id>
    <nct_id>NCT00673803</nct_id>
  </id_info>
  <brief_title>Influence of Two Different Preloaded Intraocular Lens (IOLs) on Posterior Capsule Opacification</brief_title>
  <official_title>Influence of Two Sharp-edged Hydrophobic Acrylic Micro-incision-IOLs on Posterior Capsule Opacification. A Randomized, Double-masked Study With Intraindividual Comparison.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Hietzing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Hietzing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies showed that a sharp posterior optic edge of an intraocular lens (IOL) inhibits
      migration of lens epithelial cells in between posterior capsule and optic of the IOL and
      therefore reduces the rate of posterior capsule opacification (PCO). In present time most
      IOLs implanted have a sharp posterior optic edge. Due to differences in IOL production
      different IOLs have different rates of PCO.

      Progression in cataract surgery technique allow phacoemulsification through micro-incisions.
      Therefore there is need for IOLs that can be implanted through incisions of about 2.5 mm.

      This study investigates the effect of two different hydrophobic acrylic IOLs with a sharp
      posterior optic edge on the rate of PCO after implantation through a micro-incision. The
      results will be compared intraindividually.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      prospective, randomized, bilateral study with intraindividual comparison, implantation of a
      Polylens Y10 IOL in one eye and implantation of a Polylens Y30 in the contralateral eye.

      PCO rate will be detected at 1 year and 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PCO rate</measure>
    <time_frame>2 years after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>cataract surgery, implantation of a Polylens Y10</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>cataract surgery, implantation of a Polylens Y30</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cataract surgery</intervention_name>
    <description>cataract surgery with implantation of an IOL</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <other_name>Polylens Y30 IOL, Polytech, Germany</other_name>
    <other_name>Polylens Y10 IOL, Polytech, Germany</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bilateral age-related cataract

          -  age 55 to 80 years

          -  expected postoperative visual acuity of at least 0.5

        Exclusion Criteria:

          -  amblyopia

          -  corneal scars

          -  diabetes

          -  pseudoexfoliation-syndrome

          -  earlier ocular surgeries or laser treatments

          -  intraocular tumors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadja Karnik, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept of Ophthalmology, Hietzing Hospital, Vienna, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology, Hietzing Hospital</name>
      <address>
        <city>Vienna</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2008</study_first_submitted>
  <study_first_submitted_qc>May 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2008</study_first_posted>
  <last_update_submitted>August 16, 2010</last_update_submitted>
  <last_update_submitted_qc>August 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2010</last_update_posted>
  <responsible_party>
    <name_title>Matthias Wirtitsch MD</name_title>
    <organization>Hietzing Hospital, Vienna, Austria</organization>
  </responsible_party>
  <keyword>posterior capsule opacification</keyword>
  <keyword>micro incision</keyword>
  <keyword>sharp optic edge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Capsule Opacification</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

